UnknownNot Applicable

Different Level of ECSWT in Post Mastectomy Lymphedema

Egypt45 participantsStarted 2023-03-01

Plain-language summary

to investigate the effectiveness of different dosages of ECSW in the treatment of post mastectomy lymphedema volume and quality of life (Qol)

Age range30 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Their ages ranged from 30 to 50 years.
✓. All patients were examined carefully by physician before the study procedure.
✓. All patients were free from any other pathological conditions or histories of other health abnormalities except arm lymphedema.
✓. They had undergone radical or modified radical mastectomy with axillary lymph node dissection with or without radiotherapy intervention.
✓. Only ambulant subjects without any aides will be selected.
✓. The degree of lymphedema in all subjects was grade 2 to 3 according to the classification of Foldi.(Foldi et al., 2006), (Appendix II ).
✓. All patients will be medically stable.
✓. Each patient will sign a consent form which in that insures her eligibility in the study.

✕. The patients had recurrent malignancy, active infection, and clinical evidence of obstructive venous diseases.
✕. Patients contraindicated to ESWT due to bilateral, acute, and chronic inflammation as well as due to metastasis and poor skin condition were excluded.
✕. The patients had neurological or orthopedic problems, and diabetes.
✕. Patients with primary lymphedema.
✕. Cardiopulmonary disease which decrease the patient activites.

lymphedema volume

Timeframe: two months

skin thickness of the arm

Timeframe: two months

NCT IDNCT06278298

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-01

Who can participate

Age range30 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Their ages ranged from 30 to 50 years.
✓. All patients were examined carefully by physician before the study procedure.
✓. All patients were free from any other pathological conditions or histories of other health abnormalities except arm lymphedema.
✓. They had undergone radical or modified radical mastectomy with axillary lymph node dissection with or without radiotherapy intervention.
✓. Only ambulant subjects without any aides will be selected.
✓. The degree of lymphedema in all subjects was grade 2 to 3 according to the classification of Foldi.(Foldi et al., 2006), (Appendix II ).
✓. All patients will be medically stable.
✓. Each patient will sign a consent form which in that insures her eligibility in the study.

✕. The patients had recurrent malignancy, active infection, and clinical evidence of obstructive venous diseases.
✕. Patients contraindicated to ESWT due to bilateral, acute, and chronic inflammation as well as due to metastasis and poor skin condition were excluded.
✕. The patients had neurological or orthopedic problems, and diabetes.
✕. Patients with primary lymphedema.
✕. Cardiopulmonary disease which decrease the patient activites.